First Generic Ropinirole, Approved by The FDA
Filed in archive FDA Approvals , Neurological Disorders , Treatment on May 9, 2008
Requip (ropinirole hydrochloride) tablets - product of GlaxoSmithKline (GSK) - are for the treatment of moderate to severe Restless Legs Syndrome (RLS).

© Brymo
From the NINDS-NIH:
Restless legs syndrome (RLS) is a neurological disorder characterized by unpleasant sensations in the legs and an uncontrollable urge to move when at rest in an effort to relieve these feelings. RLS sensations are often described by people as burning, creeping, tugging, or like insects crawling inside the legs. Often called paresthesias (abnormal sensations) or dysesthesias (unpleasant abnormal sensations), the sensations range in severity from uncomfortable to irritating to painful.
Now the FDA has approved the generic versions of Requip - Ropinirole Hydrochloride. The said generics approved are from the following generic drug makers:
- Roxane Laboratories Inc.
- Teva Pharmaceuticals USA
- Par Pharmaceuticals Inc.
- Mylan Pharmaceuticals Inc.
Read more from the FDA News.
Tags: Requip Ropinirole Hydrochloride Restless Legs Syndrome health contact+lenses
Vote for First Generic Ropinirole, Approved by The FDA:
|
Rating: 6.67 out of 3 vote(s) cast.
|
Response from:
Trusted.MD Network
Requip (ropinirole hydrochloride) tablets - product of GlaxoSmithKline (GSK) - are for the treatment of moderate to severe Restless Legs Syndrome (RLS).
© Brymo
Most Popular
Allergies
Alzheimer's Disease
Arthritis
Bacteria and Bacterial Infections
Best of
Blog Carnivals
Bone Health
Cancer
Cardiovascular Health
Cases
CFS
Consumer Alert
Controversies
Dental Health
Diabetes
Diagnostics
Diarrhea
Did you know
Diet
Dietary Supplements and Vitamins
